Featured Articles

1. A Risk-Based Approach To Validation Studies For Sterilizing-Grade Filtration And Single-Use Systems 10/3/2024

   One way to address risk related to product quality is by implementing a Question-based Review approach. Read on to learn about this approach and its advantages.

2. Biopharma's Battle With Scope 3 Emissions 9/3/2024

   Given the numerous stakeholders involved throughout a product's lifecycle and the limited direct control companies have, how can biopharma organizations effectively measure and manage Scope 3 emissions?

3. 2024 Biopharma Sustainability Review Findings 9/3/2024

   What actions are biopharma leaders worldwide taking to enhance sustainability? What challenges are they encountering? And how can the broader industry learn from the companies paving the way?

4. Eco-Design Yields Sustainability Gains — Why Is It So Hard? 9/3/2024

   Explore some of the biggest obstacles companies are encountering and what is already being done to move the industry closer to significant sustainability progress and environmental achievements.

5. The Business Case For Sustainability ― From Industry Resilience To Bottom Line Impact 9/3/2024

   Explore key insights into how sustainability efforts are influencing business outcomes from a survey that collected data from 800 pharma and biopharma executives across 18 countries.

6. 2024 Global Biopharma Sustainability Review 9/3/2024

   What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?

7. PUPSIT As Part Of A Contamination Control Strategy (CCS) 8/21/2024

   Learn about the changes introduced in the latest revision to EU GMP Annex 1, and gain insight into the components that should be part of a PUPSIT risk assessment.

8. When Should Filter Validation Be Performed? 8/21/2024

   Learn about a program that has been developed to facilitate risk mitigation before process-specific filter validation is performed.

9. The Scalability Of Depth Filters For CHO Cell Culture Clarification 7/19/2024

   Clarification using depth filtration is standard in monoclonal antibody (mAb) manufacturing. Here, we showcase the scalability of Stax™ mAx depth filters, demonstrating their effectiveness.

10. Is Industry Ready To Take A Bite Out Of Obesity? 7/15/2024

    What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?